Bal Pharma
76.95
-0.64(-0.82%)
Market Cap₹122.51 Cr
PE Ratio15.11
IndustryHealthcare
Company Performance:
1D-0.82%
1M+13.33%
6M-5.35%
1Y-27.41%
5Y-10.78%
View Company Insightsright
More news about Bal Pharma
29Jul 25
Bal Pharma Schedules Board Meeting to Discuss Q1 Results, ESOP, and Subsidiary Merger
Bal Pharma has scheduled a Board of Directors meeting for August 11, 2025, with a comprehensive agenda. Key items include reviewing Q1 financial results, planning the 38th AGM, considering an Employee Stock Option Plan-2025, and potentially merging subsidiary Lifezen Healthcare Pvt Ltd. A trading window closure is in effect from June 1 to August 14, 2025, for designated persons and employees.
 no imag found
Bal Pharma
76.95
-0.64
(-0.82%)
1 Year Returns:-27.41%
Industry Peers
Sun Pharmaceutical
1,659.50
(-0.34%)
Divis Laboratories
6,280.00
(-0.10%)
Torrent Pharmaceuticals
4,087.60
(-1.16%)
Lupin
2,307.80
(-0.16%)
Dr Reddys Laboratories
1,220.50
(-0.01%)
Cipla
1,234.20
(+0.14%)
Zydus Life Science
931.05
(+0.26%)
Mankind Pharma
2,227.00
(+1.23%)
Aurobindo Pharma
1,408.60
(+1.21%)
Alkem Laboratories
5,668.50
(-0.49%)